JUL 01, 2020 8:00 AM PDT

Applied Biosystems™ TaqPath™ COVID-19 Combo Kit*: A highly sensitive, specific, and robust real-time PCR test

Speakers
  • Senior Director, Product Management Genetic Science Division, Clinical Solutions, Thermo Fisher Scientific
    Biography
      Lauren is responsible for leading the Product Management team to develop solutions for Infectious Disease, Oncology and Pharmacogenomics - including for COVID-19 Real-time PCR products. In her most recent roles, Lauren served as the Director of Marketing at McKesson and Director of Emerging Markets at Cepheid, generating commercial strategy, product positioning and marketing campaign initiatives for specialty providers and molecular diagnostics, respectively. Her earlier roles included positions with Becton Dickinson Biosciences, Becton Dickinson Global Health and Johnson & Johnson. Lauren received her MBA from the Kellogg School of Management at Northwestern University, and a Bachelor of Science from Cornell University.
    • Managing Principal Scientist , Molecular Diagnostics, HealthTrack, Rx
      Biography
        Dr. Vijay Singh is the Managing Principal Scientist for Molecular Diagnostics at HealthTrackRx in Denton Texas where he has been in this role for 3 years. In his current role he is leading molecular tests for pathogen targets on qPCR nanofluidics platform. Prior to this role he did his PhD in Molecular Biology and Post-Doctoral training in Metabolic Engineering at University of North Texas.
      • Professor of Genetics Rutgers University; COO RUCDR Infinite Biologics; CSO Brooks Life Sciences
        Biography
          Dr. Andy Brooks is the Chief Operating Officer and Director of Technology Development of RUCDR Infinite Biologics at Rutgers University. As the COO, Dr. Brooks oversees the operations of all laboratories within RUCDR, ensuring consistent and superior quality standards for all services. RUCDR Infinite Biologics, is the world's largest university-based biorepository with a focus on creating and implementing technologies for biomaterial quality control and sample chain of custody. Dr. Brooks is a molecular neuroscientist, whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for both nucleic acid and protein analyses. He has worked to automate and develop the service infrastructure to provide high-throughput sample management and analysis for DNA, RNA, and protein-based technologies to hundreds of labs globally.

        Abstract

        DATE:  July 1, 2020

        TIME:   8:00 am PDT, 11:00 am EDT

         

        In late 2019, researchers identified the SARS-CoV-2 pathogen as the virus responsible for COVID-19. The virus spread rapidly throughout the world and was declared a global health concern by the World Health Organization. At the end of January 2020, Thermo Fisher Scientific launched a SARS-CoV-2 pathogen detection assay, which was quickly developed into a multiplex kit containing highly specific assays and controls targeting three different regions of the SARS-CoV-2 genome. The kit was approved for Emergency Use Authorization (EUA) by the United States Food and Drug Administration in March, and has since been used as a central component of other EUA approved protocols.

         

        Learning Objectives:

        • The development of Applied Biosystems™ TaqPath™ COVID-19 Combo Kit, including target selection
        • Performance data and the Thermo Fisher Scientific EUA protocol
        • Performance data from clinical laboratories using the TaqPath COVID-19 Combo Kit for the detection of RNA from SARS-CoV-2 under their own EUA protocols
        • A list of all approved EUA test kits and protocols can be found here

         

        * For Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.

         

         

        *The content in this webinar pertains to the Applied Biosystems TaqPath COVID-19 Combo Kit which is registered for use in the United States of America, Australia, New Zealand, Canada, Israel, South Africa, India, Indonesia, Malaysia, The Philippines, Singapore and Taiwan.

         

        Webinars will be available for unlimited on-demand viewing after live event.

         

        LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


        Show Resources
        You May Also Like
        SEP 10, 2020 9:00 AM PDT
        C.E. CREDITS
        SEP 10, 2020 9:00 AM PDT
        Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
        APR 07, 2020 8:00 AM PDT
        C.E. CREDITS
        APR 07, 2020 8:00 AM PDT
        DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
        JUN 17, 2020 1:30 PM PDT
        C.E. CREDITS
        JUN 17, 2020 1:30 PM PDT
        Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
        NOV 10, 2020 7:00 AM PST
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        NOV 10, 2020 7:00 AM PST
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
        JUN 09, 2020 10:00 AM PDT
        C.E. CREDITS
        JUN 09, 2020 10:00 AM PDT
        DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
        MAY 08, 2020 10:00 AM PDT
        C.E. CREDITS
        MAY 08, 2020 10:00 AM PDT
        DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
        Loading Comments...
        Show Resources
        Attendees
        • See more